Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs SIEB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: NMR 5 – 1 SIEB Matrix Metrics: NMR 9 – 1 SIEB

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Siebert Financial Corp (SIEB) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas SIEB carries 44.3/100 (HOLD) at $1.74 (38.3x Forward P/E, -0.2% operating margin).

  • Growth vs. Quality Trade-Off: NMR earns the overall head-to-head edge with a stronger Unified Composite Score (44.5/100 HOLD vs. SIEB 44.3/100 HOLD) and 1.03β · 29% Vol risk profile, whereas SIEB leads top-line expansion (+109.4% YoY revenue growth, 0.72x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile SIEB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs SIEB
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
SIEB NASDAQ
Siebert Financial Corp
Security Brokers, Dealers & Flotation Companies
$1.74
+5.45% 1D
Market Cap $70.1M
TTM Revenue $104M
Forward P/E 38.3x
Beta / 30D Vol 0.27β · 48% Vol
Unified Composite Score
44.3 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 37
RSI-14: 37.1 · SMA20: $1.83 · SMA50: $2.07

6-Pillar Scorecard Institutional Category Breakdown (NMR 5 – 1 SIEB)

Columns: Metric · NMR · SIEB
1. Valuation Multiples NMR
Forward P/E 12.7x 38.3x
Trailing P/E 11.2x 38.3x
PEG Ratio 0.81x 0.72x
EV / Revenue 1.9x 0.6x
2. Growth & Scale NMR
Revenue Growth (YoY) +17.9% +109.4%
Earnings Growth (YoY) +13.6% -58.0%
TTM Revenue (USD) $14.9B $104M
Market Cap $28.3B $70.1M
3. Profitability & Quality NMR
Gross Margin 77.4% 90.8%
Operating Margin 25.1% -0.2%
Net Profit Margin 17.1% -1.1%
Return on Equity (ROE) 11.5% -1.2%
4. Balance Sheet & Cash Flow SIEB
Cash Generation (TTM) N/A $13M
Cash Flow Margin N/A 12.3%
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $4.6M Net Cash
Dividend Yield 3.34% None (0.00%)
5. Options & Positioning NMR
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 30.7% (<1st %ile) 571.4% (100th %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat NMR
OpEx & R&D Intensity 52.3% of Rev ($7.77B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (9) vs SIEB (1)
Institutional Metric NMR SIEB Criterion Row Edge
Market Capitalization
Scale
$28.3B $70.1M Larger Scale NMR
Trailing P/E Ratio
Valuation
11.2x 38.3x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 38.3x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% +109.4% Higher Growth SIEB
Operating Margin (TTM)
Profitability
25.1% -0.2% Higher Margin NMR
Net Profit Margin
Profitability
17.1% -1.1% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
11.5% -1.2% Higher ROE NMR
52-Week Range Position
Momentum
60% ($7–$11) 9% ($1–$4) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 0.27β · 48% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 44.3 / 100 (HOLD) Higher Composite NMR
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $104M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 90.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 0.72x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) $13M ($4.6M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +10.3 pp
NMR: +2.36% · SIEB: -7.94%
3M Horizon NMR +12.45 pp
NMR: -1.84% · SIEB: -14.29%
6M Horizon NMR +16.12 pp
NMR: +16.69% · SIEB: +0.57%
1Y Horizon NMR +63.73 pp
NMR: +26.32% · SIEB: -37.41%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs SIEB. Trailing 12-month operating profitability (NMR 25.1% vs SIEB -0.2%) and valuation multiples (NMR 12.7x vs SIEB 38.3x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
SIEB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$104M
Gross Margin90.8%
Op. Margin-0.2%
ROE / Fwd P/E-1.2% · 38.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SIEB BREAKDOWN
47d in phase · OBV DISTRIBUTION
Current IV 571.4%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact SIEB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
SIEB Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $70.1M market capitalization and -0.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs SIEB Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Siebert Financial Corp (SIEB) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas SIEB carries 44.3/100 (HOLD) at $1.74 (38.3x Forward P/E, -0.2% operating margin). Growth vs. Quality Trade-Off: NMR earns the overall head-to-head edge with a stronger Unified Composite Score (44.5/100 HOLD vs. SIEB 44.3/100 HOLD) and 1.03β · 29% Vol risk profile, whereas SIEB leads top-line expansion (+109.4% YoY revenue growth, 0.72x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile SIEB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with SIEB at +109.4% YoY revenue growth and -58.0% YoY earnings growth on $104M TTM revenue (90.8% gross margin, -0.2% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $104M for SIEB. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SIEB.

NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas SIEB trades at 38.3x Forward P/E, 38.3x Trailing P/E, 0.72x PEG, and 0.6x EV/Revenue (12.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus SIEB (-1.2% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, SIEB carries 571.4% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.27β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.